{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:16:49Z","timestamp":1792588609594,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10157-025-02726-4","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T08:02:40Z","timestamp":1751529760000},"page":"1764-1782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive analysis of pyroptosis-related gene signatures in renal fibrosis"],"prefix":"10.1007","volume":"29","author":[{"given":"Dao-Hai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-6976","authenticated-orcid":false,"given":"Bo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"1","key":"2726_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tem.2023.09.001","volume":"35","author":"N Yamashita","year":"2024","unstructured":"Yamashita N, Kramann R. Mechanisms of kidney fibrosis and routes towards therapy. Trends Endocrinol Metab. 2024;35(1):31\u201348.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"2726_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.kint.2016.08.025","volume":"91","author":"L Gewin","year":"2017","unstructured":"Gewin L, Zent R, Pozzi A. Progression of chronic kidney disease: too much cellular talk causes damage. Kidney Int. 2017;91(3):552\u201360.","journal-title":"Kidney Int"},{"issue":"7841","key":"2726_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41586-020-2941-1","volume":"589","author":"C Kuppe","year":"2021","unstructured":"Kuppe C, et al. Decoding myofibroblast origins in human kidney fibrosis. Nature. 2021;589(7841):281\u20136.","journal-title":"Nature"},{"issue":"4","key":"2726_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrneph.2014.246","volume":"11","author":"LL Falke","year":"2015","unstructured":"Falke LL, et al. Diverse origins of the myofibroblast\u2014implications for kidney fibrosis. Nat Rev Nephrol. 2015;11(4):233\u201344.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"2726_CR5","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.kint.2017.09.033","volume":"93","author":"B-C Liu","year":"2018","unstructured":"Liu B-C, et al. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 2018;93(3):568\u201379.","journal-title":"Kidney Int"},{"issue":"5","key":"2726_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41581-023-00694-0","volume":"19","author":"AB Sanz","year":"2023","unstructured":"Sanz AB, et al. Regulated cell death pathways in kidney disease. Nat Rev Nephrol. 2023;19(5):281\u201399.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2726_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13408","volume":"329","author":"C Oh","year":"2025","unstructured":"Oh C, Spears TJ, Aachoui Y. Inflammasome-mediated pyroptosis in defense against pathogenic bacteria. Immunol Rev. 2025;329(1): e13408.","journal-title":"Immunol Rev"},{"issue":"1","key":"2726_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/med.22071","volume":"45","author":"J Wang","year":"2025","unstructured":"Wang J, et al. Pyroptosis and the fight against lung cancer. Med Res Rev. 2025;45(1):5\u201328.","journal-title":"Med Res Rev"},{"issue":"5","key":"2726_CR9","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18(5):1106\u201321.","journal-title":"Cell Mol Immunol"},{"key":"2726_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101849","volume":"70","author":"L Dejas","year":"2023","unstructured":"Dejas L, et al. Regulated cell death in neutrophils: From apoptosis to NETosis and pyroptosis. Semin Immunol. 2023;70: 101849.","journal-title":"Semin Immunol"},{"issue":"7","key":"2726_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41419-023-06005-6","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. Pyroptosis in renal inflammation and fibrosis: current knowledge and clinical significance. Cell Death Dis. 2023;14(7):472.","journal-title":"Cell Death Dis"},{"issue":"11","key":"2726_CR12","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/ki.2009.86","volume":"75","author":"RL Chevalier","year":"2009","unstructured":"Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 2009;75(11):1145\u201352.","journal-title":"Kidney Int"},{"issue":"1","key":"2726_CR13","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1038\/s41467-024-47315-3","volume":"15","author":"L Li","year":"2024","unstructured":"Li L, et al. Inhibition of ACSS2-mediated histone crotonylation alleviates kidney fibrosis via IL-1\u03b2-dependent macrophage activation and tubular cell senescence. Nat Commun. 2024;15(1):3200.","journal-title":"Nat Commun"},{"issue":"12","key":"2726_CR14","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1681\/ASN.0000000000000446","volume":"35","author":"X Liu","year":"2024","unstructured":"Liu X, et al. Lysosomal-associated protein transmembrane 5, tubular senescence, and progression of CKD. J Am Soc Nephrol. 2024;35(12):1655\u201370.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2726_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41597-019-0095-5","volume":"6","author":"M Pavkovic","year":"2019","unstructured":"Pavkovic M, et al. Multi omics analysis of fibrotic kidneys in two mouse models. Sci Data. 2019;6(1):92.","journal-title":"Sci Data"},{"issue":"1","key":"2726_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1681\/ASN.2018060644","volume":"30","author":"AY Higashi","year":"2019","unstructured":"Higashi AY, Aronow BJ, Dressler GR. Expression profiling of fibroblasts in chronic and acute disease models reveals novel pathways in kidney fibrosis. J Am Soc Nephrol. 2019;30(1):80\u201394.","journal-title":"J Am Soc Nephrol"},{"issue":"741","key":"2726_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adj0133","volume":"16","author":"Z Pan","year":"2024","unstructured":"Pan Z, et al. Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease. Sci Transl Med. 2024;16(741): e0133.","journal-title":"Sci Transl Med"},{"issue":"6","key":"2726_CR18","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1681\/ASN.2015020225","volume":"27","author":"FL Craciun","year":"2016","unstructured":"Craciun FL, et al. RNA sequencing identifies novel translational biomarkers of kidney fibrosis. J Am Soc Nephrol. 2016;27(6):1702\u201313.","journal-title":"J Am Soc Nephrol"},{"issue":"D1","key":"2726_CR19","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2012","unstructured":"Barrett T, et al. NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res. 2012;41(D1):D991\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2726_CR20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s12885-022-09526-z","volume":"22","author":"H Chen","year":"2022","unstructured":"Chen H, et al. Identification of a pyroptosis-related prognostic signature in breast cancer. BMC Cancer. 2022;22(1):429.","journal-title":"BMC Cancer"},{"key":"2726_CR21","doi-asserted-by":"publisher","first-page":"1029717","DOI":"10.3389\/fgene.2022.1029717","volume":"13","author":"G Zhong","year":"2022","unstructured":"Zhong G, et al. Development of a novel pyroptosis-related LncRNA signature with multiple significance in acute myeloid leukemia. Front Genet. 2022;13:1029717.","journal-title":"Front Genet"},{"issue":"1","key":"2726_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41420-021-00451-x","volume":"7","author":"Y Ye","year":"2021","unstructured":"Ye Y, Dai Q, Qi H. A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer. Cell Death Discov. 2021;7(1):71.","journal-title":"Cell Death Discov"},{"issue":"2","key":"2726_CR23","doi-asserted-by":"publisher","first-page":"2435487","DOI":"10.1080\/0886022X.2024.2435487","volume":"46","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Diverse regulated cell death patterns and immune traits in kidney allograft with fibrosis: a prediction of renal allograft failure based on machine learning, single-nucleus RNA sequencing and molecular docking. Ren Fail. 2024;46(2):2435487.","journal-title":"Ren Fail"},{"issue":"6472","key":"2726_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav1741","volume":"366","author":"SE McGeary","year":"2019","unstructured":"McGeary SE, et al. The biochemical basis of microRNA targeting efficacy. Science. 2019;366(6472): eaav1741.","journal-title":"Science"},{"issue":"D1","key":"2726_CR25","first-page":"D148","volume":"48","author":"HY Huang","year":"2020","unstructured":"Huang HY, et al. miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database. Nucleic Acids Res. 2020;48(D1):D148-d154.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2726_CR26","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","volume":"44","author":"D Szklarczyk","year":"2016","unstructured":"Szklarczyk D, et al. STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. Nucleic Acids Res. 2016;44(D1):D380\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2726_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang R, Fu P, Ma L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther. 2023;8(1):129.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"2726_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1159\/000531642","volume":"9","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Li Q. The role of pyroptosis in the pathogenesis of kidney diseases. Kidney Dis (Basel). 2023;9(6):443\u201358.","journal-title":"Kidney Dis (Basel)"},{"key":"2726_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110691","volume":"108","author":"S Yang","year":"2023","unstructured":"Yang S, et al. Hyperforin regulates renal fibrosis via targeting the PI3K-AKT\/ICAM1 axis. Cell Signal. 2023;108: 110691.","journal-title":"Cell Signal"},{"key":"2726_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176799","volume":"978","author":"M Wen","year":"2024","unstructured":"Wen M, et al. Dihydromyricetin ameliorates diabetic renal fibrosis via regulating SphK1 to suppress the activation of NF-\u03baB pathway. Eur J Pharmacol. 2024;978: 176799.","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"2726_CR31","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/s41401-020-0475-6","volume":"41","author":"ZQ Chen","year":"2020","unstructured":"Chen ZQ, et al. Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway. Acta Pharmacol Sin. 2020;41(12):1587\u201396.","journal-title":"Acta Pharmacol Sin"},{"issue":"16","key":"2726_CR32","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1113\/JP275952","volume":"596","author":"WQ Han","year":"2018","unstructured":"Han WQ, et al. Membrane rafts-redox signalling pathway contributes to renal fibrosis via modulation of the renal tubular epithelial-mesenchymal transition. J Physiol. 2018;596(16):3603\u201316.","journal-title":"J Physiol"},{"key":"2726_CR33","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.2147\/DDDT.S420135","volume":"17","author":"M Feng","year":"2023","unstructured":"Feng M, et al. Network pharmacology analysis and machine-learning models confirmed the ability of YiShen HuoXue decoction to alleviate renal fibrosis by inhibiting pyroptosis. Drug Des Devel Ther. 2023;17:3169\u201392.","journal-title":"Drug Des Devel Ther"},{"key":"2726_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106350","volume":"182","author":"H Zhao","year":"2022","unstructured":"Zhao H, et al. Lacticaseibacillus rhamnosus Fmb14 prevents purine induced hyperuricemia and alleviate renal fibrosis through gut-kidney axis. Pharmacol Res. 2022;182: 106350.","journal-title":"Pharmacol Res"},{"issue":"1","key":"2726_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40659-023-00416-7","volume":"56","author":"X Cui","year":"2023","unstructured":"Cui X, et al. Alpha-kinase1 promotes tubular injury and interstitial inflammation in diabetic nephropathy by canonical pyroptosis pathway. Biol Res. 2023;56(1):5.","journal-title":"Biol Res"},{"key":"2726_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.858494","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, et al. Blockade of autophagy prevents the progression of hyperuricemic nephropathy through inhibiting NLRP3 inflammasome-mediated pyroptosis. Front Immunol. 2022;13: 858494.","journal-title":"Front Immunol"},{"key":"2726_CR37","doi-asserted-by":"publisher","first-page":"1247382","DOI":"10.3389\/fimmu.2024.1247382","volume":"15","author":"F Bai","year":"2024","unstructured":"Bai F, et al. Integrated analysis reveals crosstalk between pyroptosis and immune regulation in renal fibrosis. Front Immunol. 2024;15:1247382.","journal-title":"Front Immunol"},{"issue":"14","key":"2726_CR38","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.7150\/thno.32352","volume":"9","author":"W Chen","year":"2019","unstructured":"Chen W, et al. Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation. Theranostics. 2019;9(14):3980\u201391.","journal-title":"Theranostics"},{"key":"2726_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104312","volume":"86","author":"S Xu","year":"2022","unstructured":"Xu S, et al. Leukemia inhibitory factor is a therapeutic target for renal interstitial fibrosis. EBioMedicine. 2022;86: 104312.","journal-title":"EBioMedicine"},{"key":"2726_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110430","volume":"121","author":"D Wang","year":"2023","unstructured":"Wang D, et al. TSLP\/TSLPR promotes renal fibrosis by activating STAT3 in renal fibroblasts. Int Immunopharmacol. 2023;121: 110430.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"2726_CR41","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41419-019-2085-0","volume":"10","author":"C Zheng","year":"2019","unstructured":"Zheng C, et al. Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice. Cell Death Dis. 2019;10(11):848.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2726_CR42","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1515\/biol-2022-0506","volume":"17","author":"Y Yuan","year":"2022","unstructured":"Yuan Y, et al. Aggravated renal fibrosis is positively associated with the activation of HMGB1-TLR2\/4 signaling in STZ-induced diabetic mice. Open Life Sci. 2022;17(1):1451\u201361.","journal-title":"Open Life Sci"},{"issue":"11","key":"2726_CR43","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s00592-024-02312-2","volume":"61","author":"YY Xu","year":"2024","unstructured":"Xu YY, et al. Melatonin inhibits circadian gene DEC1 and TLR2\/MyD88\/NF-\u03baB signaling pathway to alleviate renal injury in type 2 diabetic mice. Acta Diabetol. 2024;61(11):1455\u201374.","journal-title":"Acta Diabetol"},{"issue":"5","key":"2726_CR44","doi-asserted-by":"publisher","first-page":"779","DOI":"10.33549\/physiolres.935378","volume":"73","author":"L Bai","year":"2024","unstructured":"Bai L, et al. Trimethylamine induced chronic kidney injury by activating the ZBP1-NLRP3 inflammasome pathway. Physiol Res. 2024;73(5):779\u201389.","journal-title":"Physiol Res"},{"issue":"8023","key":"2726_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-024-07611-w","volume":"632","author":"SM Theparambil","year":"2024","unstructured":"Theparambil SM, et al. Adenosine signalling to astrocytes coordinates brain metabolism and function. Nature. 2024;632(8023):139\u201346.","journal-title":"Nature"},{"issue":"1","key":"2726_CR46","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12931-023-02513-3","volume":"24","author":"X Lai","year":"2023","unstructured":"Lai X, et al. Dexmedetomidine alleviates pulmonary fibrosis through the ADORA2B-Mediated MAPK signaling pathway. Respir Res. 2023;24(1):214.","journal-title":"Respir Res"},{"issue":"1","key":"2726_CR47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1096\/fj.14-260182","volume":"29","author":"H Karmouty-Quintana","year":"2015","unstructured":"Karmouty-Quintana H, et al. Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension. Faseb j. 2015;29(1):50\u201360.","journal-title":"Faseb j"},{"issue":"11","key":"2726_CR48","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1096\/fj.201700219R","volume":"31","author":"K Philip","year":"2017","unstructured":"Philip K, et al. HIF1A up-regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis. Faseb j. 2017;31(11):4745\u201358.","journal-title":"Faseb j"},{"key":"2726_CR49","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3389\/fphys.2018.00555","volume":"9","author":"TCJ Mertens","year":"2018","unstructured":"Mertens TCJ, et al. Switching-Off Adora2b in vascular smooth muscle cells halts the development of pulmonary hypertension. Front Physiol. 2018;9:555.","journal-title":"Front Physiol"},{"issue":"10","key":"2726_CR50","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/art.40554","volume":"70","author":"H Karmouty-Quintana","year":"2018","unstructured":"Karmouty-Quintana H, et al. The antifibrotic effect of A(2B) adenosine receptor antagonism in a mouse model of dermal fibrosis. Arthritis Rheumatol. 2018;70(10):1673\u201384.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"2726_CR51","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12931-024-03011-w","volume":"25","author":"S Zhou","year":"2024","unstructured":"Zhou S, et al. MiR-125b-5p alleviates pulmonary fibrosis by inhibiting TGF\u03b21-mediated epithelial-mesenchymal transition via targeting BAK1. Respir Res. 2024;25(1):382.","journal-title":"Respir Res"},{"issue":"6","key":"2726_CR52","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/jb\/mvac025","volume":"171","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang Z, Wang M. MiR-29a regulates cardiomyocyte apoptosis by targeting Bak1 in diabetic cardiomyopathy. J Biochem. 2022;171(6):663\u201371.","journal-title":"J Biochem"},{"issue":"10","key":"2726_CR53","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00109-017-1556-y","volume":"95","author":"E Patsenker","year":"2017","unstructured":"Patsenker E, et al. 4-O\u2019-methylhonokiol protects from alcohol\/carbon tetrachloride-induced liver injury in mice. J Mol Med (Berl). 2017;95(10):1077\u201389.","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"2726_CR54","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jep.2011.06.030","volume":"137","author":"J Li","year":"2011","unstructured":"Li J, et al. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats. J Ethnopharmacol. 2011;137(1):714\u201323.","journal-title":"J Ethnopharmacol"},{"key":"2726_CR55","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.omtn.2019.05.018","volume":"17","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Richards AM, Wang P. MicroRNA-221 is cardioprotective and anti-fibrotic in a rat model of myocardial infarction. Mol Ther Nucleic Acids. 2019;17:185\u201397.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"12","key":"2726_CR56","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/art.41041","volume":"71","author":"A Kozlova","year":"2019","unstructured":"Kozlova A, et al. Regulation of fibroblast apoptosis and proliferation by MicroRNA-125b in systemic sclerosis. Arthritis Rheumatol. 2019;71(12):2068\u201380.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"2726_CR57","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/CIRCULATIONAHA.116.026644","volume":"136","author":"AC Finney","year":"2017","unstructured":"Finney AC, et al. EphA2 expression regulates inflammation and fibroproliferative remodeling in atherosclerosis. Circulation. 2017;136(6):566\u201382.","journal-title":"Circulation"},{"key":"2726_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156047","volume":"135","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, et al. Catalpol ameliorates liver fibrosis via inhibiting aerobic glycolysis by EphA2\/FAK\/Src signaling pathway. Phytomedicine. 2024;135: 156047.","journal-title":"Phytomedicine"},{"issue":"3","key":"2726_CR59","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbrc.2017.07.122","volume":"491","author":"AY Leem","year":"2017","unstructured":"Leem AY, et al. All-trans retinoic acid attenuates bleomycin-induced pulmonary fibrosis via downregulating EphA2-EphrinA1 signaling. Biochem Biophys Res Commun. 2017;491(3):721\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2726_CR60","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12882-024-03688-7","volume":"25","author":"G Chen","year":"2024","unstructured":"Chen G, et al. Research progress on miR-124-3p in the field of kidney disease. BMC Nephrol. 2024;25(1):252.","journal-title":"BMC Nephrol"},{"issue":"1","key":"2726_CR61","doi-asserted-by":"publisher","first-page":"18076","DOI":"10.1038\/s41598-023-45188-y","volume":"13","author":"W Xia","year":"2023","unstructured":"Xia W, et al. Knockdown of lncRNA MALAT1 attenuates renal interstitial fibrosis through miR-124-3p\/ITGB1 axis. Sci Rep. 2023;13(1):18076.","journal-title":"Sci Rep"},{"issue":"1","key":"2726_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114194","volume":"442","author":"C Zhang","year":"2024","unstructured":"Zhang C, et al. Mechanistic study on lncRNA XIST\/miR-124-3p\/ITGB1 axis in renal fibrosis in obstructive nephropathy. Exp Cell Res. 2024;442(1): 114194.","journal-title":"Exp Cell Res"},{"issue":"4","key":"2726_CR63","doi-asserted-by":"publisher","first-page":"10399","DOI":"10.1080\/21655979.2022.2056816","volume":"13","author":"J Hao","year":"2022","unstructured":"Hao J, et al. Silencing of LncRNA KCNQ1OT1 confers an inhibitory effect on renal fibrosis through repressing miR-124-3p activity. Bioengineered. 2022;13(4):10399\u2013411.","journal-title":"Bioengineered"},{"key":"2726_CR64","doi-asserted-by":"publisher","first-page":"1326026","DOI":"10.3389\/fimmu.2024.1326026","volume":"15","author":"ZY Duan","year":"2024","unstructured":"Duan ZY, et al. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy. Front Immunol. 2024;15:1326026.","journal-title":"Front Immunol"},{"issue":"5","key":"2726_CR65","doi-asserted-by":"publisher","first-page":"755","DOI":"10.33549\/physiolres.935305","volume":"73","author":"M Xu","year":"2024","unstructured":"Xu M, et al. MiR-92a-3p promotes renal injury and fibrosis through facilitating M1 macrophage polarization via targeting LIN28A. Physiol Res. 2024;73(5):755\u201367.","journal-title":"Physiol Res"},{"issue":"4","key":"2726_CR66","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4103\/ejpi.EJPI-D-24-00019","volume":"67","author":"M Xu","year":"2024","unstructured":"Xu M, et al. MiR-92a-3p knockdown attenuates transforming growth factor-\u03b21-induced tubulointerstitial fibrosis by targeting LIN28A-mediated EMT pathway. J Physiol Investig. 2024;67(4):198\u2013206.","journal-title":"J Physiol Investig"},{"issue":"1","key":"2726_CR67","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41598-022-27353-x","volume":"13","author":"N Salah","year":"2023","unstructured":"Salah N, et al. Evaluation of the role of kefir in management of non-alcoholic steatohepatitis rat model via modulation of NASH linked mRNA-miRNA panel. Sci Rep. 2023;13(1):236.","journal-title":"Sci Rep"},{"issue":"4","key":"2726_CR68","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ki.2014.244","volume":"86","author":"VS Roberts","year":"2014","unstructured":"Roberts VS, et al. The role of adenosine receptors A2A and A2B signaling in renal fibrosis. Kidney Int. 2014;86(4):685\u201392.","journal-title":"Kidney Int"},{"key":"2726_CR69","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mam.2017.01.004","volume":"55","author":"C Oyarz\u00fan","year":"2017","unstructured":"Oyarz\u00fan C, et al. Adenosine contribution to normal renal physiology and chronic kidney disease. Mol Aspects Med. 2017;55:75\u201389.","journal-title":"Mol Aspects Med"},{"issue":"10","key":"2726_CR70","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1016\/j.transproceed.2014.09.151","volume":"46","author":"V Roberts","year":"2014","unstructured":"Roberts V, et al. Adenosine receptor expression in the development of renal fibrosis following ischemic injury. Transplant Proc. 2014;46(10):3257\u201361.","journal-title":"Transplant Proc"},{"issue":"3","key":"2726_CR71","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1681\/ASN.0000000000000294","volume":"35","author":"A Permyakova","year":"2024","unstructured":"Permyakova A, et al. Renal mitochondrial ATP transporter ablation ameliorates obesity-induced CKD. J Am Soc Nephrol. 2024;35(3):281\u201398.","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02726-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02726-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02726-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T11:02:07Z","timestamp":1764241327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02726-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":71,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2726"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02726-4","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no relevant financial or non-financial competing interests to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}